myMobility Phase 0 Clinical Study
Research payments
$4,198,969
Through program year 2025, $4,198,969 in research payments was reported against myMobility Phase 0 Clinical Study, across 479 payments, paid by Zimmer Biomet Holdings, Inc..
- Paid by
- Zimmer Biomet Holdings, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $2,300 | 2 |
| 2024 | Research | $231,658 | 56 |
| 2023 | Research | $542,569 | 67 |
| 2022 | Research | $1,065,033 | 79 |
| 2021 | Research | $916,383 | 96 |
| 2020 | Research | $790,204 | 102 |
| 2019 | Research | $650,824 | 77 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Paul Duwelius Portland, OR Named on 33 payments
- Jeremy Gililland Salt Lake City, UT Named on 24 payments
- Craig Israelite Philadelphia, PA Named on 20 payments
- James Huddleston Redwood City, CA Named on 20 payments
- James Ballard Oregon City, OR Named on 17 payments
- Craig Della Valle Chicago, IL Named on 16 payments
- Adolph Lombardi New Albany, OH Named on 15 payments
- Steven Barnett Orange, CA Named on 14 payments
- Todd Miner Denver, CO Named on 13 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.